SLCO4A1 Polyclonal antibody

SLCO4A1 Polyclonal Antibody for IP, ELISA
Cat No. 26399-1-AP

产品说明书

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

IP, ELISA and More (1)

OATP-E, OATPE, OATP4A1, OATP1, OATP RP1

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  Unconjugated
规格: 

-/ -


经过测试的应用

Positive IP detected inL02 cells

推荐稀释比

应用推荐稀释比
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

发表文章中的应用

WBSee 1 publications below

产品信息

26399-1-AP targets SLCO4A1 in WB, IP, ELISA applications and shows reactivity with human samples.

经测试应用 IP, ELISA Application Description
文献引用应用WB
经测试反应性 human
文献引用反应性human
免疫原 SLCO4A1 fusion protein Ag23905 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Polyclonal
产品类型 Antibody
全称 solute carrier organic anion transporter family, member 4A1
别名 OATP-E, OATPE, OATP4A1, OATP1, OATP RP1
计算分子量 77 kDa
观测分子量 77 kDa
GenBank蛋白编号BC015727
基因名称 SLCO4A1
Gene ID (NCBI) 28231
RRIDAB_2880501
偶联类型 Unconjugated
形式 Liquid
纯化方式Antigen affinity purification
UNIPROT IDQ96BD0
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

SLCO4A (Solute carrier organic anion transporter family member 4A1), also referred to as OATP4A1, is a membrane transporter protein, primarily facilitates the transmembrane transport of substances that are independent of Na+, including lipid‑soluble drugs, thyroid and adrenal hormones, and a selected few toxin (PMID: 38275113). SLCO4A1 is highly expressed in several cancers and promotes cell proliferation, migration and invasion (PMID: 28378090). Besides, SLCO4A1 was highly expressed in pancreatic cancer and could be a potential biomarker to target anticancer drugs to pancreatic carcinoma (PMID: 34924768).

实验方案

Product Specific Protocols
IP protocol for SLCO4A1 antibody 26399-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

发表文章

SpeciesApplicationTitle
humanWB

Cell Res

Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells.

Authors - Fei Peng
Loading...